Dingdang Health Technology Group (9886.HK) Action Cours

Dingdang Health Technology Group Ltd. generates revenue through its Pharmaceutical and Healthcare Business segment, which offers online direct sales, business distribution, offline smart pharmacies, express delivery services, and online medical consultation. The company also earns income from the Others segment, providing marketing services, marketplace services, and other services. Its primary customers are domestic consumers and businesses within China, leveraging its domestic market focus. The firm operates two distinct business segments to serve the pharmaceutical and healthcare needs of its target market. The company's Pharmaceutical and Healthcare Business segment focuses on delivering healthcare solutions through multiple channels, including online platforms and physical smart pharmacies, while the Others segment supports these operations with complementary services like marketing and marketplace solutions. Both segments operate exclusively within the domestic market, targeting Chinese consumers and businesses seeking pharmaceutical and healthcare services. Dingdang Health Technology Group Ltd. utilizes its two business segments to maximize revenue streams from domestic healthcare service delivery. Revenue is derived from the direct sale of pharmaceutical products, distribution services, and healthcare-related online consultations, alongside marketing and marketplace services provided to other businesses. The company’s domestic market strategy ensures that all services and products are tailored to meet the needs of Chinese consumers and businesses, with no international operations. Its business model relies on the integration of online and offline services to enhance customer experience and drive sales.